Aristotle University Of Thessaloniki (AUTH)
Δείκτες φλεγμονής και ενεργοποίησης των ποδοκυττάρων σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 και διαβητική νεφροπάθεια
Abstract
dc:descriptionDiabetic nephropathy is a complication of diabetes mellitus and main cause of increased morbidity and mortality. Its pathogenesis is multifactorial and includes metabolic and hemodynamic factors, influenced by genetic and environmental factors. Recent evidence suggests that chronic subclinical inflammation and podocyte activation consist common pathways of DN development and progression. Tumor necrosis factor-α (TNF-α), and its receptors, 1 and 2 (TNFR1, TNFR2), are important mediators of chronic inflammation. Their serum levels are increased in DN and their role in renal function outcome has been lately recognized. Moreover, under inflammatory conditions, podocytes may act as antigen presenting cells (APCs), processing MHC II antigens to initiate specific T cell responses. Activation of podocytes requires besides the interaction between MHC II and T cell receptor, an additional non-specific signal, generated by the interaction of co-stimulatory molecules B7–1 and CD28. Some investigators, but not all, have reported increased podocyte expression of B7–1 in patients with DN. The present cross-sectional study aimed to investigate the role of TNF-α signaling pathway and podocyte activation in the development of DN, and their possible association with albuminuria and renal function impairment. Eighty-two patients with type 2 DM entered the study. Patients' demographic, anthropometric and clinical characteristics as well as medication at time of enrolment were recorded. The presence and severity of DN was estimated based on albumin/creatinine ratio (ACR, μg/mg). The study was approved by the Hospital's Institutional Review Board and informed consent was obtained by all participants prior to study enrolment. Measurements of serum of TNF-α, TNFR1, TNFR2, CD28, B7–1 and CTLA-4 and urine TNF-α were performed at the Research Laboratory of the Department of Nephrology Aristotle University, at General Hospital of Thessaloniki, Hippokratio, by enzyme-linked immunoabsorbent assay (ELISA). Diabetic patients [39 male, age 69.5 (56–78) years] were divided into three groups, based on Albumin/Creatinine ratio (ACR) levels, Group I (ACR<30 μg/mg, n=20), Group II (ACR 30–300 μg/mg, n=31), Group III (ACR>300 μg/mg, n=31). Statistically significant differences were observed in the concentrations of urinary TNF-α (p<0.001), serum TNFR1 (p<0.001), serum TNFR2 (p<0.001), CTLA4 (p<0.001) and CD28 (p=0.034), Groups I, II, III, respectively. In multivariate analysis, independent parameters correlated with ACR were serum TNFR1 (p= 0.003), TNFR2 (p=0.0012) and urinary TNF-α (p=0.015) levels. ROC analyses showed that CRP, urinary TNF-α, serum TNFR2, B7-1 and CTLA-4 had a significant predictive value for the presence of ACR>30 μg/mg. ROC analyses showed that CRP, urinary TNF-α, serum TNFR1 and TNFR2 had a significant predictive value for CKD. In conclusion, our study is the first one that supports the importance of TNF-α signaling pathway and podocyte activation at early stages of DN. Both pathways participate in the development of albuminuria, and probably act synergistically in the development of overt proteinuria and decline of renal function.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lampropoulou, Ioanna - Theologia
- Λαμπροπούλου, Ιωάννα - Θεολογία
Subjects
dc:subject × 14- Διαβητική νεφροπάθεια
- Σακχαρώδης διαβήτης τύπου 2
- Δείκτες φλεγμονής
- Δείκτες ενεργοποίησης ποδοκυττάρων
- Diabetic nephropathy
- Diabetes mellitus type 2
- Inflammatory markers
- Podocyte activaion markers
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Νεφρολογία
- Clinical Medicine
- Medical and Health Sciences
- Nephrology
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48928